VETINUITY
FDA lists human-labeled dextrose injection in shortage, with various concentrations showing available, limited, or unavailable supply.
The FDA currently lists human-labeled dextrose injection in shortage, with presentations ranging from available to limited availability or unavailable across multiple manufacturers.
Dextrose: human-labeled FDA records matched to our veterinary drug catalog.
| FDA field | Product-specific value |
|---|---|
| Record 1 | Dextrose Monohydrate 10% Injection |
| FDA generic name | Dextrose Monohydrate 10% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-04) |
| Company | Baxter Healthcare |
| First posted | 03/01/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0338-0023-04 |
| Record 2 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-9666-35) |
| Company | Baxter Healthcare |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0338-9666-35 |
| Record 3 | Dextrose Monohydrate 10% Injection |
| FDA generic name | Dextrose Monohydrate 10% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-03) |
| Company | Baxter Healthcare |
| First posted | 03/01/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0338-0023-03 |
| Record 4 | Dextrose Monohydrate 10% Injection |
| FDA generic name | Dextrose Monohydrate 10% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-20) |
| Company | B. Braun Medical Inc. |
| First posted | 03/01/2022 |
| FDA updated | 10/19/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0264-7520-20 |
| Record 5 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-11) |
| Company | Baxter Healthcare |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Unavailable |
| FDA additional information | Estimated recovery: November 2026 |
| Package NDC | 0338-0017-11 |
| Record 6 | Dextrose Monohydrate 70% Injection |
| FDA generic name | Dextrose Monohydrate 70% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | DEXTROSE 70% IN PLASTIC CONTAINER, Injection, 70 g/100 mL (NDC 0990-7918-19) |
| Company | Otsuka ICU Medical LLC |
| First posted | 10/11/2024 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. |
| Package NDC | 0990-7918-19 |
| Record 7 | Dextrose Monohydrate 50% Injection |
| FDA generic name | Dextrose Monohydrate 50% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 76329-3302-1) |
| Company | Amphastar Pharmaceuticals, Inc. |
| First posted | 01/13/2022 |
| FDA updated | 11/06/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Pediatric |
| Presentation availability | Limited Availability |
| FDA additional information | Not stated |
| Package NDC | 76329-3302-1 |
| Record 8 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-36) |
| Company | Otsuka ICU Medical LLC |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. |
| Package NDC | 0990-7923-36 |
| Record 9 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-38) |
| Company | Baxter Healthcare |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0338-0017-38 |
| Record 10 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 2.5 g/50 mL (NDC 0338-9664-40) |
| Company | Baxter Healthcare |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0338-9664-40 |
| Record 11 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0078-20) |
| Company | Baxter Healthcare |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0338-0078-20 |
| Record 12 | Dextrose Monohydrate 70% Injection |
| FDA generic name | Dextrose Monohydrate 70% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | DEXTROSE 70% IN PLASTIC CONTAINER, Injection, 70 g/100 mL (NDC 0990-7120-07) |
| Company | Otsuka ICU Medical LLC |
| First posted | 10/11/2024 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. |
| Package NDC | 0990-7120-07 |
| Record 13 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 0264-1510-31) |
| Company | B. Braun Medical Inc. |
| First posted | 02/14/2022 |
| FDA updated | 11/10/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0264-1510-31 |
| Record 14 | Dextrose Monohydrate 10% Injection |
| FDA generic name | Dextrose Monohydrate 10% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-74) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 03/01/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Limited Availability |
| FDA additional information | Check wholesalers for inventory |
| Package NDC | 63323-824-74 |
| Record 15 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-31) |
| Company | Baxter Healthcare |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0338-0017-31 |
| Record 16 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 0264-1510-32) |
| Company | B. Braun Medical Inc. |
| First posted | 02/14/2022 |
| FDA updated | 11/10/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0264-1510-32 |
| Record 17 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-10) |
| Company | Baxter Healthcare |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0338-0017-10 |
| Record 18 | Dextrose Monohydrate 70% Injection |
| FDA generic name | Dextrose Monohydrate 70% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose Monohydrate 70%, Injection, 70 g/100 mL (NDC 0338-0719-06) |
| Company | Baxter Healthcare |
| First posted | 10/11/2024 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0338-0719-06 |
| Record 19 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-00) |
| Company | B. Braun Medical Inc. |
| First posted | 02/14/2022 |
| FDA updated | 10/19/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0264-7510-00 |
| Record 20 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-09) |
| Company | Otsuka ICU Medical LLC |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Limited Availability |
| FDA additional information | On Allocation. Estimated Recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. |
| Package NDC | 0990-7922-09 |
| Record 21 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-13) |
| Company | Otsuka ICU Medical LLC |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. |
| Package NDC | 0990-7923-13 |
| Record 22 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0070-10) |
| Company | Baxter Healthcare |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0338-0070-10 |
| Record 23 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-02) |
| Company | Baxter Healthcare |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0338-0017-02 |
| Record 24 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-03) |
| Company | Otsuka ICU Medical LLC |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Limited Availability |
| FDA additional information | On Allocation. Estimated Recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. |
| Package NDC | 0990-7922-03 |
| Record 25 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-458-30) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Limited Availability |
| FDA additional information | Check wholesalers for inventory |
| Package NDC | 65219-458-30 |
| Record 26 | Dextrose Monohydrate 10% Injection |
| FDA generic name | Dextrose Monohydrate 10% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-76) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 03/01/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Limited Availability |
| FDA additional information | Check wholesalers for inventory |
| Package NDC | 63323-824-76 |
| Record 27 | Dextrose Monohydrate 10% Injection |
| FDA generic name | Dextrose Monohydrate 10% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-00) |
| Company | B. Braun Medical Inc. |
| First posted | 03/01/2022 |
| FDA updated | 10/19/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0264-7520-00 |
| Record 28 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-55) |
| Company | Otsuka ICU Medical LLC |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. |
| Package NDC | 0990-7922-55 |
| Record 29 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-20) |
| Company | Otsuka ICU Medical LLC |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. |
| Package NDC | 0990-7923-20 |
| Record 30 | Dextrose Monohydrate 10% Injection |
| FDA generic name | Dextrose Monohydrate 10% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7938-19) |
| Company | Otsuka ICU Medical LLC |
| First posted | 03/01/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Unavailable |
| FDA additional information | Product discontinued. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. |
| Package NDC | 0990-7938-19 |
| Record 31 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-460-20) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Limited Availability |
| FDA additional information | Check wholesalers for inventory |
| Package NDC | 65219-460-20 |
| Record 32 | Dextrose Monohydrate 10% Injection |
| FDA generic name | Dextrose Monohydrate 10% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-09) |
| Company | Otsuka ICU Medical LLC |
| First posted | 03/01/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Limited Availability |
| FDA additional information | On Allocation. Estimated Recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. |
| Package NDC | 0990-7930-09 |
| Record 33 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-462-10) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Limited Availability |
| FDA additional information | Check wholesalers for inventory |
| Package NDC | 65219-462-10 |
| Record 34 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-41) |
| Company | Baxter Healthcare |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0338-0017-41 |
| Record 35 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0551-11) |
| Company | Baxter Healthcare |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0338-0551-11 |
| Record 36 | Dextrose Monohydrate 10% Injection |
| FDA generic name | Dextrose Monohydrate 10% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-03) |
| Company | Otsuka ICU Medical LLC |
| First posted | 03/01/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Limited Availability |
| FDA additional information | On Allocation. Estimated Recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. |
| Package NDC | 0990-7930-03 |
| Record 37 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-02) |
| Company | Otsuka ICU Medical LLC |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Limited Availability |
| FDA additional information | On Allocation. Estimated Recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. |
| Package NDC | 0990-7922-02 |
| Record 38 | Dextrose Monohydrate 10% Injection |
| FDA generic name | Dextrose Monohydrate 10% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-02) |
| Company | Otsuka ICU Medical LLC |
| First posted | 03/01/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Limited Availability |
| FDA additional information | On Allocation. Estimated Recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. |
| Package NDC | 0990-7930-02 |
| Record 39 | Dextrose Monohydrate 50% Injection |
| FDA generic name | Dextrose Monohydrate 50% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-7517-16) |
| Company | Hospira, Inc., a Pfizer Company |
| First posted | 01/13/2022 |
| FDA updated | 11/09/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Pediatric |
| Presentation availability | Unavailable |
| FDA additional information | Next Delivery: November 2026; Estimated Recovery: September 2027; Shortage per Manufacturer: Manufacturing Delay |
| Package NDC | 0409-7517-16 |
| Record 40 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0074-30) |
| Company | Baxter Healthcare |
| First posted | 07/20/2026 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0338-0074-30 |
| Record 41 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-23) |
| Company | Otsuka ICU Medical LLC |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. |
| Package NDC | 0990-7923-23 |
| Record 42 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-48) |
| Company | Baxter Healthcare |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Unavailable |
| FDA additional information | Estimated recovery: December 2026 |
| Package NDC | 0338-0017-48 |
| Record 43 | Dextrose Monohydrate 10% Injection |
| FDA generic name | Dextrose Monohydrate 10% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-10) |
| Company | B. Braun Medical Inc. |
| First posted | 03/01/2022 |
| FDA updated | 10/19/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0264-7520-10 |
| Record 44 | Dextrose Monohydrate 10% Injection |
| FDA generic name | Dextrose Monohydrate 10% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-75) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 03/01/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Limited Availability |
| FDA additional information | Check wholesalers for inventory |
| Package NDC | 63323-824-75 |
| Record 45 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-456-60) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Limited Availability |
| FDA additional information | Check wholealers for inventory |
| Package NDC | 65219-456-60 |
| Record 46 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0551-18) |
| Company | Baxter Healthcare |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0338-0551-18 |
| Record 47 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-20) |
| Company | B. Braun Medical Inc. |
| First posted | 02/14/2022 |
| FDA updated | 10/19/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0264-7510-20 |
| Record 48 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-37) |
| Company | Otsuka ICU Medical LLC |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. |
| Package NDC | 0990-7923-37 |
| Record 49 | Dextrose Monohydrate 70% Injection |
| FDA generic name | Dextrose Monohydrate 70% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose Monohydrate 70%, Injection, 70 g/100 mL (NDC 0264-7387-50) |
| Company | B. Braun Medical Inc. |
| First posted | 10/11/2024 |
| FDA updated | 11/10/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0264-7387-50 |
| Record 50 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-03) |
| Company | Baxter Healthcare |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0338-0017-03 |
| Record 51 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-18) |
| Company | Baxter Healthcare |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0338-0017-18 |
| Record 52 | Dextrose Monohydrate 50% Injection |
| FDA generic name | Dextrose Monohydrate 50% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-6648-02) |
| Company | Hospira, Inc., a Pfizer Company |
| First posted | 01/13/2022 |
| FDA updated | 11/09/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Pediatric |
| Presentation availability | Limited Availability |
| FDA additional information | Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay |
| Package NDC | 0409-6648-02 |
| Record 53 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-61) |
| Company | Otsuka ICU Medical LLC |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Limited Availability |
| FDA additional information | On Allocation. Estimated Recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. |
| Package NDC | 0990-7922-61 |
| Record 54 | Dextrose Monohydrate 10% Injection |
| FDA generic name | Dextrose Monohydrate 10% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-02) |
| Company | Baxter Healthcare |
| First posted | 03/01/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0338-0023-02 |
| Record 55 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-10) |
| Company | B. Braun Medical Inc. |
| First posted | 02/14/2022 |
| FDA updated | 10/19/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0264-7510-10 |
| Record 56 | Dextrose Monohydrate 5% Injection |
| FDA generic name | Dextrose Monohydrate 5% Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-464-50) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 02/14/2022 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Presentation availability | Limited Availability |
| FDA additional information | Check wholesalers for inventory |
| Package NDC | 65219-464-50 |
In diabetic dogs and cats undergoing anesthesia, perioperative blood glucose monitoring is recommended to guide insulin and dextrose administration. For patients with hypernatremia, slow intravenous administration of 5 percent dextrose in water or other hypotonic fluids replaces the water deficit over 48 to 72 hours to prevent cerebral edema.
Dextrose 50% is the constrained concentration. Hospira lists 25 g/50 mL (NDC 0409-7517-16) as Unavailable, with next delivery November 2026 and estimated recovery March 2027, and NDC 0409-6648-02 as Limited Availability with estimated recovery December 2026. Amphastar lists its 25 g/50 mL (NDC 76329-3302-1) as Limited Availability. Dextrose 70% presentations from Otsuka ICU Medical, Baxter Healthcare and B. Braun Medical are listed as Available.
As of 2026-11-08, dextrose is absent from the FDA CVM animal drug shortage table. This does not establish product availability.
Vetinuity supports treatment options with citations and dose math.
FDA shortage status details for clindamycin injection, including manufacturer availability and supply dates.
Track veterinary and human drug shortages using FDA Center for Veterinary Medicine tables and CDER records.
FDA lists human-labeled dexmedetomidine injection in shortage, while Dexdomitor provides 0.1 mg/mL and 0.5 mg/mL veterinary formulations.
FDA shortage status by lidocaine injection presentation, plus lidocaine and bupivacaine onset and duration for local blocks in dogs and cats.
In the saved FDA dextrose records, Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-04) from Baxter Healthcare has availability listed as Available. This describes that presentation in the checked snapshot.
As of 2026-11-08, dextrose is absent from the FDA CVM animal drug shortage table. This does not establish product availability.
Vetinuity explains clinical options with journal citations.
The veterinarian diagnoses and prescribes.